Shanghai, China

Xin Zhi Ma

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Shenzhen, CN (2013)
  • Ningbo, CN (2023)
  • Shanghai, CN (2014 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Innovator Xin Ma: Pioneering Advances in Metabolic Disease Treatment

Introduction: Xin Ma, based in Shanghai, China, is an accomplished inventor known for his contributions to the field of metabolic disease treatment. With a unique strain designated as SSYD-3, Xin’s innovation showcases remarkable advancements over existing treatments, focusing on both efficacy and safety.

Latest Patents: Xin Ma holds a notable patent for a strain aimed at preventing and treating metabolic diseases. The patent details a specific strain named SSYD-3, which is documented under accession number CGMCC No. 14764. This strain boasts superior fermentation performance, storage stability, acid and bile resistance compared to the previously established ATCC BAA835 strain. The significant enhancements offered by SSYD-3 present a promising avenue for effectively managing metabolic disorders.

Career Highlights: Throughout his career, Xin has made substantial contributions while working for reputable organizations, including Sph Sine Pharmaceutical Laboratories Co., Ltd and Shanghai Institute of Endocrine and Metabolic Diseases. His professional journey reflects a dedication to research and innovation in metabolic health.

Collaborations: Xin Ma has collaborated with notable peers such as Bin Wen and Guang Ning. These partnerships have enriched his research endeavors, fostering an environment of shared knowledge and innovation in the fight against metabolic diseases.

Conclusion: Xin Ma’s innovative work in developing the SSYD-3 strain marks a significant milestone in the treatment of metabolic diseases. His dedication to research and collaboration within the scientific community promises to pave the way for further advancements in this critical area of health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…